CS logo
small CS logo
Qualiclinic Kft.

Budapest, Hungary
Kórház, Budapest

About Qualiclinic Kft.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
15
Amgen
4
Eli Lilly and Company
4
Galapagos NV
3
Janssen Research & Development, LLC
2
ACELYRIN Inc.
1
Boehringer Ingelheim
1
Boston Pharmaceuticals
1
Celgene
1
Coherus Biosciences, Inc.
1
Gedeon Richter Plc.
1
Total Rows: 15

Clinical Trials at Qualiclinic Kft.


During the past decade, Qualiclinic Kft. conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 24 clinical trials were completed, i.e. on average, 109.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44223322333333221122770044442222Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
2010-06-02
2016-10-27
Completed
504
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
2010-12-09
2017-08-16
Completed
529
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
2011-09-01
2014-06-01
Completed
323
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
2011-12-01
2014-03-01
Completed
183
Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
2011-11-01
2013-01-01
Completed
345
Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis
2012-05-02
2018-10-25
Completed
490
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
2013-04-01
2015-03-01
Completed
208
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
2014-01-20
2015-12-18
Completed
422

Rows per page:

1–38 of 38

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Qualiclinic Kft." #1 sponsor was "Pfizer" with 15 trials, followed by "Amgen" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Galapagos NV" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Qualiclinic Kft." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 15Pfizer: 15Amgen: 4Amgen: 4Eli Lilly and Company: 4Eli Lilly and Company: 4Galapagos NV: 3Galapagos NV: 3Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2ACELYRIN Inc.: 1ACELYRIN Inc.: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Boston Pharmaceuticals: 1Boston Pharmaceuticals: 1Celgene: 1Celgene: 1Coherus Biosciences, Inc.: 1Coherus Biosciences, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2Incyte Corporation: 2Incyte Corporation: 2Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo Co., Ltd.: 1Gilead Sciences: 1Gilead Sciences: 1Hexal AG: 1Hexal AG: 1Nektar Therapeutics: 1Nektar Therapeutics: 1Teva PharmaceuticalIndustries, Ltd.: 1Teva PharmaceuticalIndustries, Ltd.: 1

Clinical Trials Conditions at Qualiclinic Kft.


According to Clinical.Site data, the most researched conditions in "Qualiclinic Kft." are "Rheumatoid Arthritis" (11 trials), "Psoriatic Arthritis" (6 trials), "Systemic Lupus Erythematosus" (5 trials), "Arthritis, Psoriatic" (3 trials) and "Lupus Erythematosus, Systemic" (2 trials). Many other conditions were trialed in "Qualiclinic Kft." in a lesser frequency.

Clinical Trials Intervention Types at Qualiclinic Kft.


Most popular intervention types in "Qualiclinic Kft." are "Drug" (30 trials), "Biological" (7 trials), "Other" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (22 trials), "Adalimumab" (2 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Qualiclinic Kft.


The vast majority of trials in "Qualiclinic Kft." are 36 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Qualiclinic Kft.


Currently, there are NaN active trials in "Qualiclinic Kft.". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Qualiclinic Kft., undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Qualiclinic Kft., 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 18Phase 3: 18Phase 2: 15Phase 2: 15Phase 4: 4Phase 4: 4Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 29Completed: 29Active, not recruiting: 3Active, not recruiting: 3Recruiting: 3Recruiting: 3Terminated: 2Terminated: 2Unknown status: 1Unknown status: 1